These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2909725

  • 1. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM.
    J Med Chem; 1989 Jan; 32(1):13-6. PubMed ID: 2909725
    [No Abstract] [Full Text] [Related]

  • 2. 5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptor.
    Castro JL, Broughton HB, Russell MG, Rathbone D, Watt AP, Ball RG, Chapman KL, Patel S, Smith AJ, Marshall GR, Matassa VG.
    J Med Chem; 1997 Aug 01; 40(16):2491-501. PubMed ID: 9258356
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA, Griffin EP, Shankley NP, Black JW.
    Br J Pharmacol; 1999 Mar 01; 126(6):1496-503. PubMed ID: 10217545
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 01; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 6. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Garsky VM, Gilbert KF, Leighton JL, Carson KL, Mellin EC.
    J Med Chem; 1993 Dec 24; 36(26):4276-92. PubMed ID: 8277510
    [Abstract] [Full Text] [Related]

  • 7. Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
    Patel S, Chapman KL, Smith AJ, Heald A, Freedman SB.
    Ann N Y Acad Sci; 1994 Mar 23; 713():360-3. PubMed ID: 8185188
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L.
    J Med Chem; 1996 Feb 16; 39(4):860-72. PubMed ID: 8632410
    [Abstract] [Full Text] [Related]

  • 9. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring.
    Tranquillini ME, Cassarà PG, Corsi M, Curotto G, Donati D, Finizia G, Pentassuglia G, Polinelli S, Tarzia G, Ursini A, van Amsterdam FT.
    Arch Pharm (Weinheim); 1997 Nov 16; 330(11):353-7. PubMed ID: 9431027
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD.
    Mol Pharmacol; 1994 Nov 16; 46(5):943-8. PubMed ID: 7969084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
    Roberts SP, Harper EA, Watt GF, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1996 Aug 31; 118(7):1779-89. PubMed ID: 8842444
    [Abstract] [Full Text] [Related]

  • 20. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.
    Chem Pharm Bull (Tokyo); 1996 Jul 31; 44(7):1412-4. PubMed ID: 8706146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.